Triple-negative breast cancer (TNBC) is defined by a lack of expression of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of the human epidermal growth factor receptor 2 (HER2, ERBB2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.